{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T02:51:43Z","timestamp":1774925503810,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Breast cancer (BC) is one of the major causes of death worldwide. It is the most common cause of death before the age of 70\u00a0years. The incidence and mortality of BC are rapidly increasing, posing great challenges to the health system and economy of every nation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methodology<\/jats:title>\n                <jats:p>A cross-sectional analytical study was conducted at the Department of Pathology and Clinical Laboratory of the French Medical Institute for Mothers and Children (FMIC) to demonstrate the association of human epidermal growth factor receptor 2 (Her2\/Neu) and estrogen receptor (ER)\/ progesterone receptor (PR) with clinical as well as pathological parameters among women with BC. A consecutive nonprobability sampling method was used for this study over a span of one and a half years.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>One hundred twenty participants diagnosed with breast cancer were included in the study. The mean age at diagnosis was 44.58\u2009\u00b1\u200911.16\u00a0years. Out of the total patients, 68 (56.7%) were above 40\u00a0years old, 108 (90%) were married, 94 (78.3%) were multiparous, and 88 (73.3%) had a history of breastfeeding. 33.3% of cases were within the age range of menopause (40\u201350\u00a0years). The positive expression rates of ER, PR, and Her2\/neu were found to be 48.8%, 44.6%, and 44.6%, respectively, and Her2\/neu overexpression was found to be higher among ER\/PR-negative cases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In our study, we demonstrated that among Afghan women, grade II invasive ductal carcinoma, not otherwise specified, was the most common type of BC and frequently affected women above the age of 40. We also revealed that the percentage of negative ER (50.4%), negative PR (54.4%), and concordant ER\/PR-negative cases were high compared to other possibilities. Additionally, the study revealed that expression of Her2\/neu was in contrast with the expression of ER and PR receptors. The findings of our study still support the importance of performing immunohistochemical stains for hormonal receptor classification in terms of better clinical outcomes and prognosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-024-12129-5","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T08:01:53Z","timestamp":1711526513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association of hormone receptors and human epidermal growth factor receptor-2\/neu expressions with clinicopathologic factors of breast carcinoma: a cross-sectional study in a tertiary care hospital, Kabul, Afghanistan"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6759-6334","authenticated-orcid":false,"given":"Esmatullah","family":"Esmat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4554-8024","authenticated-orcid":false,"given":"Ahmed Maseh","family":"Haidary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8268-6111","authenticated-orcid":false,"given":"Ramin","family":"Saadaat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2484-1117","authenticated-orcid":false,"given":"Syeda Naghma","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syeda","family":"Aleena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9135-6990","authenticated-orcid":false,"given":"Mujtaba","family":"Haidari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4908-3495","authenticated-orcid":false,"given":"Sayed Murtaza Sadat","family":"Hofiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasrin","family":"Hussaini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmadullah","family":"Hakimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9676-0466","authenticated-orcid":false,"given":"Abdullatif","family":"Khairy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6575-8870","authenticated-orcid":false,"given":"Jamshid","family":"Abdul-Ghafar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,27]]},"reference":[{"issue":"16","key":"12129_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJMp058197","volume":"353","author":"HJ Burstein","year":"2005","unstructured":"Burstein HJ. The distinctive nature of HER2-positive breast cancers. N Engl J Med. 2005;353(16):1 Sung H, Ferlay J, Siegel RL, Laversanne M, Soer.","journal-title":"N Engl J Med"},{"issue":"1","key":"12129_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1365-2559.2006.02453.x","volume":"49","author":"LG Fulford","year":"2006","unstructured":"Fulford LG, Easton DF, Reis-Filho JS, Sofronis A, Gillett CE, Lakhani SR, et al. Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast. Histopathology. 2006;49(1):22\u201334.","journal-title":"Histopathology"},{"key":"12129_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/bcr932","volume":"6","author":"F Bray","year":"2004","unstructured":"Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res. 2004;6:229\u201339.","journal-title":"Breast Cancer Res"},{"key":"12129_CR4","unstructured":"WHO. Cancer Afghanistan. 2020 country profile [Internet]. 2020. [cited 2022 Nov 20]. Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/country-profiles\/cancer\/afg_2020.pdf."},{"issue":"4","key":"12129_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5306\/wjco.v2.i4.171","volume":"2","author":"SV Sree","year":"2011","unstructured":"Sree SV. Breast imaging: a survey. World J Clin Oncol. 2011;2(4):1 Sung H, Ferlay J, Siegel RL, Laversanne M, Soer.","journal-title":"World J Clin Oncol"},{"issue":"9","key":"12129_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2020-037513","volume":"10","author":"R Saadaat","year":"2020","unstructured":"Saadaat R, Abdul-Ghafar J, Haidary AM, Rahmani S, Atta N. Age distribution and types of breast lesions among Afghan women diagnosed by fine needle aspiration cytology (FNAC) at a tertiary care centre in Afghanistan: a descriptive cross-sectional study. BMJ Open. 2020;10(9):1\u20135.","journal-title":"BMJ Open"},{"key":"12129_CR7","unstructured":"American Cancer Society. Breast cancer early detection and diagnosis American Cancer Society recommendations for the early detection of breast cancer. Am Cancer Soc. 2016:1\u201355. Available from: https:\/\/www.cancer.org\/content\/dam\/CRC\/PDF\/Public\/8579.00.pdf."},{"issue":"10","key":"12129_CR8","first-page":"680","volume":"19","author":"J Poorolajal","year":"2016","unstructured":"Poorolajal J, Nafissi N, Akbari ME, Mahjub H, Esmailnasab N, Babaee E. Breast cancer survival analysis based on immunohistochemistry subtypes (ER\/PR\/HER2): a retrospective cohort study. Arch Iran Med. 2016;19(10):680\u20136.","journal-title":"Arch Iran Med"},{"issue":"7","key":"12129_CR9","first-page":"854","volume":"63","author":"S Mujtaba","year":"2013","unstructured":"Mujtaba S, Haroon S, Faridi N, Rashid LF. Correlation of human epidermal growth factor receptor 2 (HER-2\/neu) receptor status with hormone receptors Oestrogen Receptor, Progesterone Receptor status and other prognostic markers in breast cancer: An experience at tertiary care hospital in Karachi. J Pak Med Assoc. 2013;63(7):854\u20138.","journal-title":"J Pak Med Assoc"},{"issue":"1","key":"12129_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3322\/caac.21203","volume":"64","author":"C DeSantis","year":"2014","unstructured":"DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin. 2014;64(1):52\u201362.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"12129_CR11","first-page":"9","volume":"11","author":"CR Gore","year":"2018","unstructured":"Gore CR, Gurwale S, Sammi A, Dey I, Deshpande AH. Estrogen, progesterone, and human epidermal growth factor receptor-2 in malignant breast lesions. Med J Dr DY Patil Vidyapeeth. 2018;11(1):9\u201315.","journal-title":"Med J Dr DY Patil Vidyapeeth"},{"issue":"1","key":"12129_CR12","first-page":"87","volume":"5","author":"A Pourzand","year":"2011","unstructured":"Pourzand A, Fakhree MBA, Hashemzadeh S, Halimi M, Daryani A. Hormone receptor status in breast cancer and its relation to age and other prognostic factors. Breast Cancer Basic Clin Res. 2011;5(1):87\u201392.","journal-title":"Breast Cancer Basic Clin Res"},{"key":"12129_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/978-1-4939-8935-5_25","volume":"1897","author":"S Magaki","year":"2019","unstructured":"Magaki S, Hojat SA, Wei B, So A, Yong WH. An introduction to the performance of immunohistochemistry. Methods Mol Biol. 2019;1897:289\u201398.","journal-title":"Methods Mol Biol"},{"issue":"8","key":"12129_CR14","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1369\/0022155412449348","volume":"60","author":"T Nakata","year":"2012","unstructured":"Nakata T, Suzuki N. Chromogen-based immunohistochemical method for elucidation of the coexpression of two antigens using antibodies from the same species. J Histochem Cytochem. 2012;60(8):611\u20139.","journal-title":"J Histochem Cytochem"},{"issue":"11","key":"12129_CR15","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.5858\/arpa.2016-0450-CP","volume":"141","author":"TA Longacre","year":"2017","unstructured":"Longacre TA, Broaddus R, Chuang LT, Cohen MB, Jarboe EA, Mutter GL, et al. Template for reporting results of biomarker testing of specimens from patients with carcinoma of the endometrium. Arch Pathol Lab Med. 2017;141(11):1508\u201312.","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"12129_CR16","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","volume":"25","author":"AC Wolff","year":"2007","unstructured":"Wolff AC, Hammond MEH, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, et al. American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007;25(1):118\u201345.","journal-title":"J Clin Oncol"},{"issue":"09","key":"12129_CR17","doi-asserted-by":"publisher","first-page":"811","DOI":"10.4236\/jct.2015.69089","volume":"06","author":"M Almumen","year":"2015","unstructured":"Almumen M. Immunohistochemical expression of VEGF in relation to other pathological parameters of breast carcinoma. J Cancer Ther. 2015;06(09):811\u201320.","journal-title":"J Cancer Ther"},{"issue":"8","key":"12129_CR18","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/modpathol.3800388","volume":"18","author":"JS Meyer","year":"2005","unstructured":"Meyer JS, Alvarez C, Milikowski C, Olson N, Russo I, Russo J, et al. Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: Reproducibility of grade and advantages of proliferation index. Mod Pathol. 2005;18(8):1067\u201378.","journal-title":"Mod Pathol"},{"issue":"1","key":"12129_CR19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3329\/fmcj.v14i1.46158","volume":"14","author":"MM Roshed","year":"2020","unstructured":"Roshed MM, Kamal S, Hossain SM, Akhtar S. Evaluation of breast cancer subtypes based on ER\/PR and Her2 expression: a clinicopathologic study of hormone receptor status (ER\/PR\/HER2-neu) in breast cancer. Faridpur Med Coll J. 2020;14(1):8\u201312.","journal-title":"Faridpur Med Coll J"},{"key":"12129_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12907-018-0081-4","volume":"19","author":"NA Aman","year":"2019","unstructured":"Aman NA, Doukoure B, Koffi KD, Koui BS, Traore ZC, Kouyate M, et al. HER2 overexpression and correlation with other significant clinicopathologic parameters in ivorian breast cancer women 11 medical and health sciences 1112 oncology and carcinogenesis. BMC Clin Pathol. 2019;19:1.","journal-title":"BMC Clin Pathol."},{"key":"12129_CR21","doi-asserted-by":"publisher","unstructured":"Sohail SK, Sarfraz R, Imran M, Kamran M, Qamar S. Estrogen and Progesterone Receptor Expression in Breast Carcinoma and Its Association With Clinicopathological Variables Among the Pakistani Population. Cureus. 2020;12(8):e9751. https:\/\/doi.org\/10.7759\/cureus.9751.","DOI":"10.7759\/cureus.9751"},{"issue":"SUPPL. 4","key":"12129_CR22","first-page":"891","volume":"105","author":"MS Wolff","year":"1997","unstructured":"Wolff MS, Weston A. Breast cancer risk and environmental exposures. Environ Health Perspect. 1997;105(SUPPL. 4):891\u20136.","journal-title":"Environ Health Perspect"},{"issue":"4","key":"12129_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijerph18041871","volume":"18","author":"DJ Bowen","year":"2021","unstructured":"Bowen DJ, Poole SF, White M, Lyn R, Flores DA, Haile HG, et al. The role of stress in breast cancer incidence: risk factors, interventions, and directions for the future. Int J Environ Res Public Health. 2021;18(4):1\u201315.","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"12129_CR24","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/s41370-022-00451-8","volume":"32","author":"LE Koval","year":"2022","unstructured":"Koval LE, Dionisio KL, Friedman KP, Isaacs KK, Rager JE. Environmental mixtures and breast cancer: identifying co-exposure patterns between understudied vs breast cancer-associated chemicals using chemical inventory informatics. J Expo Sci Environ Epidemiol. 2022;32(6):794\u2013807.","journal-title":"J Expo Sci Environ Epidemiol"},{"issue":"3","key":"12129_CR25","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/sj.bjc.6602712","volume":"93","author":"G Ursin","year":"2005","unstructured":"Ursin G, Bernstein L, Lord SJ, Karim R, Deapen D, Press MF, et al. Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Br J Cancer. 2005;93(3):364\u201371.","journal-title":"Br J Cancer"},{"issue":"1","key":"12129_CR26","first-page":"1","volume":"15","author":"JL Kelsey","year":"1993","unstructured":"Kelsey JL, Gammon MD, John EM. Reproductive factors and breast. Cancer. 1993;15(1):1 Sung H, Ferlay J, Siegel RL, Laversanne M, Soer.","journal-title":"Cancer"},{"key":"12129_CR27","doi-asserted-by":"publisher","unstructured":"Momenimovahed Z, Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer (Dove Med Press). 2019;11:151-64. https:\/\/doi.org\/10.2147\/BCTT.S176070.","DOI":"10.2147\/BCTT.S176070"},{"key":"12129_CR28","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1001\/jama.1951.03670130070024","volume":"146","author":"JR Heller","year":"1951","unstructured":"Heller JR. National cancer institute. J Am Med Assoc. 1951;146:1248.","journal-title":"J Am Med Assoc"},{"issue":"3","key":"12129_CR29","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10549-018-4796-9","volume":"170","author":"V Sopik","year":"2018","unstructured":"Sopik V, Narod SA. The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer. Breast Cancer Res Treat. 2018;170(3):647\u201356. https:\/\/doi.org\/10.1007\/s10549-018-4796-9.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"12129_CR30","doi-asserted-by":"publisher","first-page":"483","DOI":"10.4103\/ijmpo.ijmpo_98_16","volume":"38","author":"C Bansal","year":"2017","unstructured":"Bansal C, Sharma A, Pujani M, Pujani M, Sharma KL, Srivastava AN, et al. Correlation of hormone receptor and human epidermal growth factor Receptor-2\/neu expression in breast cancer with various clinicopathologic factors. Indian J Med Paediatr Oncol. 2017;38(4):483\u20139.","journal-title":"Indian J Med Paediatr Oncol"},{"issue":"4","key":"12129_CR31","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1136\/jcp.55.4.293","volume":"55","author":"G Cserni","year":"2002","unstructured":"Cserni G. Tumour histological grade may progress between primary and recurrent invasive mammary carcinoma. J Clin Pathol. 2002;55(4):293\u20137.","journal-title":"J Clin Pathol"},{"key":"12129_CR32","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3889\/oamjms.2021.6423","volume":"9","author":"D Hermansyah","year":"2021","unstructured":"Hermansyah D, Pricilia G, Azrah A, Rahayu Y, Paramita DA, Siregar ES. Correlation between grading histopathology and sentinel lymph node metastasis in early breast cancer in university of sumatera utara hospital. Open Access Maced J Med Sci. 2021;9:679\u201382.","journal-title":"Open Access Maced J Med Sci"},{"key":"12129_CR33","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/humupd\/dmi028","volume":"11","author":"JA Collins","year":"2005","unstructured":"Collins JA, Blake JM, Crosignani PG. Breast cancer risk with postmenopausal hormonal treatment. Human Reprod Update. 2005;11:545\u201360.","journal-title":"Human Reprod Update"},{"issue":"14","key":"12129_CR34","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1093\/jnci\/92.14.1126","volume":"92","author":"AM Martin","year":"2000","unstructured":"Martin AM, Weber BL. Genetic and hormonal risk factors in breast cancer. J Natl Cancer Inst. 2000;92(14):1126\u201335.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"12129_CR35","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/j.1524-4741.2009.00822.x","volume":"15","author":"CA Parise","year":"2009","unstructured":"Parise CA, Bauer KR, Brown MM, Caggiano V. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999\u20132004. Breast J. 2009;15(6):593\u2013602.","journal-title":"Breast J"},{"key":"12129_CR36","first-page":"6","volume":"22","author":"L Ayadi","year":"2008","unstructured":"Ayadi L, Khabir A, Amouri H, Karray S, Dammak A, Guermazi M, et al. Correlation of HER-2 over-expression with clinico-pathological parameters in Tunisian breast carcinoma. World J Surg Oncol. 2008;22:6.","journal-title":"World J Surg Oncol"},{"issue":"7","key":"12129_CR37","first-page":"3363","volume":"17","author":"F Shaikh","year":"2016","unstructured":"Shaikh F, Jamal Q, Baig S, Hadi NI, Majeed N. Correlation of hormone receptor and HER-2\/neu expression with clinicopathologic parameters in primary breast tumors. Asian Pacific J Cancer Prev. 2016;17(7):3363\u20137.","journal-title":"Asian Pacific J Cancer Prev"},{"issue":"4","key":"12129_CR38","first-page":"287","volume":"8","author":"R Yadav","year":"2016","unstructured":"Yadav R, Sen R, Chauhan P. ER, PR, HER2\/NEU status and relation to clinicopathological factors in breast carcinoma. Int J Pharm Pharm Sci. 2016;8(4):287\u201390.","journal-title":"Int J Pharm Pharm Sci"},{"key":"12129_CR39","doi-asserted-by":"publisher","unstructured":"Hussain A. Correlations of Hormone Receptors (ER and PR), Her2\/neu and p53 Expression in Breast Ductal Carcinoma Among Yemeni Women. The Open Cancer Immunology Journal. 2011;4:1-9. https:\/\/doi.org\/10.2174\/1876401001104010001.","DOI":"10.2174\/1876401001104010001"},{"key":"12129_CR40","doi-asserted-by":"publisher","unstructured":"Onitilo AA, Engel JM, Greenlee RT, Mukesh BN. Breast cancer subtypes based on ER\/PR and Her2 expression: comparison of clinicopathologic features and survival. Clin Med Res. 2009;7(1-2):4-13. https:\/\/doi.org\/10.3121\/cmr.2009.825.","DOI":"10.3121\/cmr.2009.825"},{"issue":"3","key":"12129_CR41","doi-asserted-by":"publisher","first-page":"171","DOI":"10.21101\/cejph.a4085","volume":"24","author":"E Pajenga","year":"2016","unstructured":"Pajenga E, Rexha T, \u00c7eliku S, Ugrinska A, Bejtja G. Hormonal receptor, human epidermal growth factor and its association with breast cancer tumor characteristics in Albania. Cent Eur J Public Health. 2016;24(3):171\u20135.","journal-title":"Cent Eur J Public Health"},{"issue":"6","key":"12129_CR42","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1136\/jcp.2004.022772","volume":"58","author":"HJ Huang","year":"2005","unstructured":"Huang HJ, Neven P, Drijkoningen M, Paridaens R, Wildiers H, Van Limbergen E, et al. Association between tumour characteristics and HER-2\/neu by immunohistochemistry in 1362 women with primary operable breast cancer. J Clin Pathol. 2005;58(6):611\u20136.","journal-title":"J Clin Pathol"},{"key":"12129_CR43","doi-asserted-by":"crossref","unstructured":"Lakshmi A. A study of correlation of expression of ER, PR and HER2\/neu receptor status with clinico-pathological parameters in breast carcinoma at a tertiary care centre. Int J Res Med Sci. 2015;1.","DOI":"10.5455\/2320-6012.ijrms20150129"},{"issue":"2","key":"12129_CR44","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1200\/JCO.2012.43.4134","volume":"31","author":"A Prat","year":"2013","unstructured":"Prat A, Cheang MCU, Mart\u00edn M, Parker JS, Carrasco E, Caballero R, et al. Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal a breast cancer. J Clin Oncol. 2013;31(2):203\u20139.","journal-title":"J Clin Oncol"},{"issue":"10","key":"12129_CR45","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1200\/JCO.2003.09.099","volume":"21","author":"VJ Bardou","year":"2003","unstructured":"Bardou VJ, Arpino G, Elledge RM, Osborne CK, Clark GM. Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases. J Clin Oncol. 2003;21(10):1973\u20139.","journal-title":"J Clin Oncol"},{"key":"12129_CR46","volume-title":"ER, PR, Her2\/neu status and relation to clinicopathological factors in breast carcinoma","author":"O Article","year":"2016","unstructured":"Article O, Yadav R, Sen R, Chauhan P. ER, PR, Her2\/neu status and relation to clinicopathological factors in breast carcinoma. 2016."},{"issue":"2","key":"12129_CR47","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00404-015-3859-y","volume":"293","author":"P Kumar","year":"2016","unstructured":"Kumar P, Aggarwal R. An overview of triple-negative breast cancer. Arch Gynecol Obstet. 2016;293(2):247\u201369.","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"12129_CR48","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/cncr.22381","volume":"109","author":"EA Rakha","year":"2007","unstructured":"Rakha EA, El-Sayed ME, Green AR, Lee AHS, Robertson JF, Ellis IO. Prognostic markers in triple-negative breast cancer. Cancer. 2007;109(1):25\u201332.","journal-title":"Cancer"},{"issue":"15","key":"12129_CR49","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","volume":"13","author":"R Dent","year":"2007","unstructured":"Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007;13(15):4429\u201334.","journal-title":"Clin Cancer Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12129-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12129-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12129-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T09:03:01Z","timestamp":1711530181000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12129-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,27]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12129"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12129-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,27]]},"assertion":[{"value":"2 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The project was approved by the Ethical Review Committee of the French Medical Institute for Mothers and Children (90-FMIC-ER-20). Guidelines laid down by research committee and ethical review committee of FMIC were followed while conducting the current research. Informed consent was obtained from all subjects and\/or their legal guardian(s) at the time of interview.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"388"}}